c="RNA sequence analysis" 1:0 1:2||t="test"||cui="C0162803"||tot="Sequence Analysis, RNA"||ns="-1000"
c="perinatal lethal form" 2:1 2:3||t="treatment"||cui="C0013058"||tot="Dosage Form"||ns="-827"
c="osteogenesis imperfecta often" 2:5 2:7||t="problem"||cui="C0029434"||tot="Osteogenesis Imperfecta"||ns="-901"
c="RNA sequence analysis" 2:38 2:40||t="test"||cui="C0162803"||tot="Sequence Analysis, RNA"||ns="-1000"
c="polymerase chain reaction technique" 2:98 2:101||t="treatment"||cui="C0556517"||tot="Chaining technique"||ns="-858"
c="Sequence analysis" 2:108 2:109||t="test"||cui="C0162801"||tot="Sequence Analysis"||ns="-1000"
c="amplified genomic DNA" 2:153 2:155||t="test"||cui="C0012854"||tot="DNA"||ns="-827"
c="osteogenesis imperfecta" 2:169 2:170||t="problem"||cui="C0029434"||tot="Osteogenesis Imperfecta"||ns="-1000"
